Oregon Health & Science University
Portland, Oregon, 97239, United States
NCT Number: NCT01148784
The purpose of this study is to compare two different soft tissue allografts, double bundle tibialis anterior allograft or quadruple bundle hamstring allograft, used in repairing a torn anterior cruciate ligament (ACL) of the knee.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Portland, Oregon, 97239, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Randomized comparison of two different allogenic tissue types, quadrupled hamstring or doubled tibialis anterior, for anterior cruciate ligament repair.
Time frame: One year
The change of physical function and pain as evaluated by patient reported outcome measures (Knee injury and Osteoarthritis Outcome Score (KOOS), International Knee Documentation Committee (IKDC) score).
Oregon Health and Science University
Other
A Prospective Randomized Comparison of Doubled Versus Quadrupled Allogenic Tissue Constructs for Anterior Cruciate Ligament Reconstruction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06529692
ACL, ACL Injury
Ann Arbor, Michigan, United States
View Trial DetailsNCT05470790
Anterior Cruciate Ligament, Injuries
Dammam, Eastern Province, Saudi Arabia
View Trial DetailsNCT07504666
Anterior Cruciate Ligament, Female Athletes
Yalova, Turkey (Türkiye)
View Trial DetailsNCT03429140
Anterior Cruciate Ligament
Lexington, Kentucky, United States
View Trial Details